Histologic, immunohistochemical, and molecular classification of 52 IPMNs of the pancreas

Applied Immunohistochemistry and Molecular Morphology

Volumn 17, Issue 1, 2009, Pages 31-39

  Chadwick, Barbara ^a   Willmore Payne, Carlynn ^b   Tripp, Sheryl ^b   Layfield, Lester J ^a,d   Hirschowitz, Sharon ^c   Holden, Joseph ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP LABORATORIES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

Intraductal papillary mucinous neoplasm; K ras; p53; Pancreas

Indexed keywords

B RAF KINASE; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; K RAS PROTEIN; MUCIN 1; MUCIN 2; PROTEIN P16; PROTEIN P21; PROTEIN P53; MUCIN; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; CANCER GRADING; CANCER INVASION; COLLOID CARCINOMA; CONTROLLED STUDY; DYSPLASIA; EPITHELIUM; GENE MUTATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; CHEMISTRY; CLASSIFICATION; EPITHELIUM CELL; GENE EXPRESSION PROFILING; GENETICS; INTESTINE TUMOR; MUTATION; PANCREAS CARCINOMA; PATHOLOGY; TUMOR GENE;

CARCINOMA, PANCREATIC DUCTAL; CLASSIFICATION; EPITHELIAL CELLS; EPITHELIUM; GENE EXPRESSION PROFILING; GENES, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL NEOPLASMS; MUCINS; MUTATION; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 58749096579     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e31817c02c6     Document Type: Article

References (28)

1. Ohhashi K, Murakami Y, Takekoshi T, et al. Four cases of "mucinproducing" cancer of the pancreas on specific findings of the papilla of Vater [abstract]. Prog Dig Endosc. 1982;20:384-1351
2. Kawarada Y, Yano T, Yamamota T, et al. Intraductal mucinproducing tumors of the pancreas. Am J Gastroenterol. 1992; 87:634-638.
3. Santini D, Campione O, Salerno A, et al. Intraductal papillarymucinous neoplasm of the pancreas. A clinicopathologic entity. Arch Pathol Lab Med. 1995;119:209-213.
4. Fukushima N, Mukai K, Kanai Y, et al. Intraductal papillary tumors and mucinous cystic tumors of the pancreas: clinicopathologic study of 38 cases. Hum Pathol. 1997;28:1010-1017. (Pubitemid 27388101)
5. Nagai E, Ueki T, Chijiiwa K, et al. Intraductal papillary mucinous neoplasms of the pancreas associated with so-called "mucinous ductal ectasia." Histochemical and immunohistochemical analysis of 29 cases. Am J Surg Pathol. 1995;19:576-589.
6. Chari ST, Yadav D, Smyrk TC, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology. 2002;123:1500-1507. (Pubitemid 35231650)
7. Maire F, Hammel P, Terris B, et al. Prognosis of malignant intraductal papillary mucinous tumors of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut. 2002;51:717-722.
8. Terris B, Ponsot P, Paye F, et al. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol. 2000;24:1372-1377. (Pubitemid 30764403)
9. Hruban PJ, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28: 977-987. (Pubitemid 38971421)
10. Luttges J, Zamboni G, Longnecker D, et al. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol. 2001;25:942-948. (Pubitemid 32594989)
11. Adsay NV, Merati K, Basturk O, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms. Delineation of an intestinal pathway of carcinogenesis in the pancreas. Am J Surg Pathol. 2004;28:839-848. (Pubitemid 38856838)
12. Adsay NV, Merati K, Andea A, et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol. 2002;15:1087-1095.
13. Hruban RH, Goggins M, Parsons J, et al. Progression model for pancreatic cancer. Clin Cancer Res. 2000;6:2969-2972.
14. Biankin AV, Kench JG, Biankin SA, et al. Pancreatic intraepithelial neoplasia in association with intraductal papillary mucinous neoplasms of the pancreas. Implications for disease progression and recurrence. Am J Surg Pathol. 2004;28:1184-1192. (Pubitemid 39121612)
15. Nakamura A, Horinouchi M, Goto M, et al. New classification of pancreatic intraductal papillary mucinous tumor by mucin expression: its relationship with potential for malignancy. J Pathol. 2002;197:201-210. (Pubitemid 34567608)
16. Willmore C, Holden JA, Zhou L, et al. Detection of C-KIT activating mutations in gastrointestinal stromal tumors by high resolution amlicon melting analysis. AJCP. 2004;122:206-216. (Pubitemid 38971353)
17. Furukawa T, Klöppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447:794-799. Epub August 9, 2005. (Pubitemid 41728866)
18. Andrejevic-Blant S, Kosmahl M, Sipos B, et al. Pancreatic intraductal papillary-mucinous neoplasms: a new and evolving entity. Virchows Arch. 2007;451:863-869. Review. Epub September 27, 2007. (Pubitemid 350060751)
19. Levi E, Klimstra DS, Andea A, et al. MUC1 and MUC2 in pancreatic neoplasia. J Clin Pathol. 2004;57:456-462.
20. Fujii H, Inagaki M, Kasai S, et al. Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol. 1997;151:1447-1454. (Pubitemid 27479775)
21. Wada K. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas. J Hepatobiliary Pancreat Surg. 2002;9:76-85.
22. Brat DJ, Lillemoe KD, Yeo CJ, et al. Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am J Surg Pathol. 1998;22:163-169.
23. Satoh K, Shimosegawa T, Moriizumi S, et al. K-ras mutation and p53 protein accumulation in intraductal mucin-hypersecreting neoplasms of the pancreas. Pancreas. 1996;12:362-368. (Pubitemid 26138629)
24. Abe K, Suda K, Arakawa A, et al. Different patterns of p16INK4A and p53 protein expressions in intraductal papillary-mucinous neoplasms and pancreatic intraepithelial neoplasia. Pancreas. 2007;34:85-91. (Pubitemid 46045725)
25. Biankin AV, Biankin SA, Kench JG, et al. Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma. Gut. 2002;50:861-868. (Pubitemid 34539051)
26. Sakai Y, Yanagisawa A, Shimada M, et al. K-ras gene mutations and loss of heterozygosity at the p53 gene locus relative to histological characteristics of mucin-producing tumors of the pancreas. Hum Pathol. 2000;31:795-803. (Pubitemid 30480449)
27. Sasaki S, Yamamoto H, Kaneto H, et al. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas. Oncol Rep. 2003;10:21-25.
28. Sessa F, Solcia E, Capella C, et al. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch. 1994;425: 357-367.